Results 61 to 70 of about 4,767,425 (261)

Standard pediatric oncology data and information technology: necessities for cancer care management [PDF]

open access: yes
Cancer is the second leading cause of death in children and survivors require life time follow-up. There is a growing recognition of the need to base cancer control policies on accurate, detailed and timely information on cancer management and outcomes ...
میرزا رحیمی, مهرداد   +3 more
core   +1 more source

Covid-19 infection in children with cancer after the first wave in Turkey: A Study of the Turkish Pediatric Oncology (TPOG) and Hematology (TPHD) Societies

open access: yes, 2021
Covid-19 infection in children with cancer after the first wave in Turkey: A Study of the Turkish Pediatric Oncology (TPOG) and Hematology (TPHD ...
Tuğcu, D.   +6 more
core  

Classical Complement Pathway Inhibition in a Pediatric Patient With Refractory Immune Thrombocytopenia

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Pediatric refractory immune thrombocytopenia (rITP) is generally characterized by persistent thrombocytopenia and failure to achieve a sustained response to multiple standard therapies. We report a 4‐year‐old female with congenital tufting enteropathy, post‐intestinal transplant patient on immunosuppressants, who developed severe rITP ...
Sarah Hsieh   +4 more
wiley   +1 more source

Histone H3.3K27M Mobilizes Multiple Cancer/Testis (CT) Antigens in Pediatric Glioma.

open access: yes, 2018
Lysine to methionine mutations at position 27 (K27M) in the histone H3 (H3.3 and H3.1) are highly prevalent in pediatric high-grade gliomas (HGG) that arise in the midline of the central nervous system.
Zhang, T   +7 more
core  

Pediatric cancer screening in hereditary gastrointestinal cancer risk syndromes: an update from the AACR childhood cancer predisposition working group

open access: yes
Gastrointestinal (GI) polyposis and cancer in pediatric patients is frequently due to an underlying hereditary cancer risk syndrome requiring ongoing cancer screening.
Schneider, K.W.   +37 more
core   +1 more source

Cell death pathways as therapeutic targets in rhabdomyosarcoma [PDF]

open access: yes, 2012
Resistance of rhabdomyosarcoma to current therapies remains one of the key issues in pediatric oncology. Since the success of most cytotoxic therapies in the treatment of cancer, for example, chemotherapy, depends on intact signaling pathways that ...
Fulda, Simone
core   +1 more source

Evidence‐Based Clinical Practice Guidelines for the Management of Pediatric Febrile Neutropenia: Resource‐Sensitive Recommendations for the Asian Continent

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Febrile neutropenia (FN) is a frequent and serious complication in children receiving cancer therapy. Standardizing FN management across Asia is challenging due to variable healthcare infrastructure, diagnostic capacity, and infection patterns; however, it could improve resource use and patient outcomes.
Joliza Patricia Cañeba   +29 more
wiley   +1 more source

Adrenocortical carcinoma masquerading as pheochromocytoma: a histopathologic dilemma

open access: yesEndocrinology, Diabetes & Metabolism Case Reports, 2020
Adrenocortical carcinoma (ACC) is an aggressive cancer that originates in the cortex of the adrenal gland and generally has a poor prognosis. ACC is rare but can be more commonly seen in those with cancer predisposition syndromes (e.g.
Impana Shetty   +8 more
doaj   +1 more source

Bone and Soft Tissue Neoplasms in Infants Versus Older Children: A Report From the Cancer in Young People in Canada Program

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background and Aims Infant bone and soft tissue neoplasms present distinct clinical challenges and lack large‐scale data to inform treatment decisions. This study aims to characterize bone and soft tissue neoplasms in infants in Canada and to compare their outcomes with those of older pediatric patients.
Samuel Sassine   +21 more
wiley   +1 more source

Pediatric Cancer Recognition Training in Botswana

open access: yesGlobal Pediatric Health, 2016
Delayed presentation of children with cancer is a significant barrier to improving the survival from children’s cancer in low- and middle-income countries (LMICs).
Jeremy S. Slone MD, MPH   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy